
HUAPONT LIFE SCIENCES CO., LTD. — Investor Relations & Filings
HUAPONT LIFE SCIENCES CO., LTD. operates as a diversified entity specializing in the research, development, manufacturing, and distribution of pharmaceutical and chemical solutions. The company holds a prominent position in the dermatology sector, providing a comprehensive range of therapeutic products for various skin disorders. Its pharmaceutical operations extend to the production of high-quality active pharmaceutical ingredients (APIs) and finished dosage forms. Beyond human health, the organization maintains a significant footprint in the agrochemical sector, focusing on the development and supply of crop protection products, including herbicides and pesticides. The company also integrates healthcare services into its business model, overseeing the operation of medical facilities and specialized clinics. Its strategic focus centers on technological advancement and the maintenance of a robust supply chain to support its global commercial activities.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 年度关联方资金占用专项审计报告 | 2022-03-18 | Chinese | |
| 2021年度业绩快报 | 2022-02-25 | Chinese | |
| 关于控股子公司山东凯盛新材料股份有限公司技术中心被认定为国家企业技术中心的公告 | 2022-02-24 | Chinese | |
| 关于董事股份减持时间过半的公告 | 2022-01-28 | Chinese | |
| 2021年第二次临时股东大会的法律意见书 | 2021-12-30 | Chinese | |
| 2021年第二次临时股东大会决议公告 | 2021-12-30 | Chinese |
Browse filings by year
23 years- 2026 49 filings
- 2025 94 filings
- 2024 76 filings
- 2023 69 filings
- 2022 61 filings
- 2021 121 filings
- 2020 134 filings
- 2019 121 filings
- 2018 204 filings
- 2017 121 filings
- 2016 128 filings
- 2015 211 filings
- 2014 200 filings
- 2013 183 filings
- 2012 112 filings
- 2011 95 filings
- 2010 80 filings
- 2009 62 filings
- 2008 66 filings
- 2007 103 filings
- 2006 60 filings
- 2005 72 filings
- 2004 39 filings
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2022
4 filings
| |||||
| 44357876 | 年度关联方资金占用专项审计报告 | 2022-03-18 | Chinese | ||
| 44357420 | 2021年度业绩快报 | 2022-02-25 | Chinese | ||
| 44357403 | 关于控股子公司山东凯盛新材料股份有限公司技术中心被认定为国家企业技术中心的公告 | 2022-02-24 | Chinese | ||
| 44357394 | 关于董事股份减持时间过半的公告 | 2022-01-28 | Chinese | ||
|
2021
11 filings
| |||||
| 44357379 | 2021年第二次临时股东大会的法律意见书 | 2021-12-30 | Chinese | ||
| 44357365 | 2021年第二次临时股东大会决议公告 | 2021-12-30 | Chinese | ||
| 44357348 | 关于增加2021年度日常关联交易预计及预计2022年度日常关联交易公告 | 2021-12-13 | Chinese | ||
| 44357334 | 对外提供财务资助管理办法(2021年12月) | 2021-12-13 | Chinese | ||
| 44357318 | 关于预计2022年度开展远期结售汇业务和人民币对外汇期权组合等业务的公告 | 2021-12-13 | Chinese | ||
| 44357307 | 关于召开2021年第二次临时股东大会的通知公告 | 2021-12-13 | Chinese | ||
| 44357292 | 第八届董事会第五次会议决议公告 | 2021-12-13 | Chinese | ||
| 44357279 | 委托理财管理制度(2021年12月) | 2021-12-13 | Chinese | ||
| 44357274 | 内部审计制度(2021年12月) | 2021-12-13 | Chinese | ||
| 44357258 | 关联交易决策制度(2021年12月) | 2021-12-13 | Chinese | ||
| 44357241 | 风险投资管理制度(2021年12月) | 2021-12-13 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
HUAPONT LIFE SCIENCES CO., LTD. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/54070/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=54070 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=54070 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=54070 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 54070}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for HUAPONT LIFE SCIENCES CO., LTD. (id: 54070)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.